Home / Pharma Healthcare / Global Pet Vaccine Market

Global Pet Vaccine Market

  • Id : RNR-54158
  • Category : Pharma Healthcare
  • Publish Date : Mar 2017
  • Pages : 109
  • Format : PDF
License Type

Description
In this report, the global Pet Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Doses), revenue (Million USD), market share and growth rate of Pet Vaccine for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Pet Vaccine market competition by top manufacturers/players, with Pet Vaccine sales volume, Price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
On the basis of product, this report displays the sales volume (K Doses), revenue (Million USD), product price (USD/Dose), market share and growth rate of each type, primarily split into
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Pet Vaccine for each application, including
Canine
Avian
Feline